These results reveal CD36-mediated fatty acid uptake as critical downstream effector of TEAD and establish the FLT3-JAK-STAT3-TAZ-TEAD-CD36 axis as a novel signaling pathway that confers TKI resistance in BP-CML cells. The gene discussed is CD36; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.